» Articles » PMID: 33973745

Indocyanine Green Versus Technetium-99m with Blue Dye for Sentinel Lymph Node Detection in Early-stage Cervical Cancer: A Systematic Review and Meta-analysis

Overview
Specialty Oncology
Date 2021 May 11
PMID 33973745
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The fluorescent dye indocyanine green (ICG) has emerged as a promising tracer for intraoperative detection of sentinel lymph nodes (SLNs) in early-stage cervical cancer. Although researchers suggest the SLN detection of ICG is equal to the more conventional combined approach of a radiotracer and blue dye, no consensus has been reached.

Aims: We aimed to assess the differences in overall and bilateral SLN detection rates with ICG versus the combined approach, the radiotracer technetium-99m ( Tc) with blue dye.

Methods And Results: We searched MEDLINE, Embase, and the Cochrane Library from inception to January 1, 2020 and included studies reporting on a comparison of SLN detection with ICG versus Tc with blue dye in early-stage cervical cancer. The overall and bilateral detection rates were pooled with random-effects meta-analyses. From 118 studies retrieved seven studies (one cross-sectional; six retrospective cohorts) were included, encompassing 589 patients. No significant differences were found in the pooled overall SLN detection rate of ICG versus Tc with blue dye. Meta-analyses of all studies showed ICG to result in a higher bilateral SLN detection rate than Tc with blue dye; 90.3% (95%CI, 79.8-100.0%) with ICG versus 73.5% (95%CI, 66.4-80.6%) with 99mTc with blue dye. This resulted in a significant and clinically relevant risk difference of 16.6% (95%CI, 5.3-28.0%). With sensitivity analysis, the risk difference of the bilateral detection rate maintained in favor of ICG but was no longer significant (13.2%, 95%CI -0.8-27.3%).

Conclusion: ICG appears to provide higher bilateral SLN detection rates compared to Tc with blue dye in patients with early-stage cervical cancer. However, in adherence with the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) guidelines, the quality of evidence is too low to provide strong recommendations and directly omit the combined approach of Tc with blue dye.

Citing Articles

Impact of Indocyanine Green Dose on Sentinel Lymph Node Mapping in Cervical Cancer: A Systematic Review.

Laufer J, Scasso S, Papadia A Cancers (Basel). 2024; 16(17).

PMID: 39272965 PMC: 11394054. DOI: 10.3390/cancers16173107.


RAISN: Robot-assisted Indocyanine Green-guided Sentinel Node Biopsy in Clinical Stage I Germ Cell Tumor.

Vermeulen-Spohn M, Pongratanakul P, Thy S, Dukart J, Albers P, Che Y Eur Urol Open Sci. 2024; 66:55-59.

PMID: 39036045 PMC: 11260343. DOI: 10.1016/j.euros.2024.06.004.


Sentinel Lymph Node Techniques in Urologic Oncology: Current Knowledge and Application.

Malkiewicz B, Kielb P, Kobylanski M, Karwacki J, Poterek A, Krajewski W Cancers (Basel). 2023; 15(9).

PMID: 37173960 PMC: 10177100. DOI: 10.3390/cancers15092495.


Personalized Sentinel Node Mapping in Endometrial Cancer by the Indocyanine Green Implementation as Single Tracer: A Case Control Study.

Cristobal Quevedo I, Cristobal Garcia I, Gracia M, Garcia-Pineda V, Alonso-Espias M, Siegrist J J Pers Med. 2023; 13(2).

PMID: 36836404 PMC: 9966782. DOI: 10.3390/jpm13020170.


Challenges in Preparation of Albumin Nanoparticle-Based Radiopharmaceuticals.

Ballinger J Molecules. 2022; 27(23).

PMID: 36500689 PMC: 9740174. DOI: 10.3390/molecules27238596.


References
1.
Guyatt G, Oxman A, Vist G, Kunz R, Falck-Ytter Y, Alonso-Coello P . GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008; 336(7650):924-6. PMC: 2335261. DOI: 10.1136/bmj.39489.470347.AD. View

2.
Holman L, Levenback C, Frumovitz M . Sentinel lymph node evaluation in women with cervical cancer. J Minim Invasive Gynecol. 2014; 21(4):540-5. PMC: 4283488. DOI: 10.1016/j.jmig.2013.12.095. View

3.
Tax C, Rovers M, de Graaf C, Zusterzeel P, Bekkers R . The sentinel node procedure in early stage cervical cancer, taking the next step; a diagnostic review. Gynecol Oncol. 2015; 139(3):559-67. DOI: 10.1016/j.ygyno.2015.09.076. View

4.
Cibula D, Abu-Rustum N, Dusek L, Zikan M, Zaal A, Sevcik L . Prognostic significance of low volume sentinel lymph node disease in early-stage cervical cancer. Gynecol Oncol. 2011; 124(3):496-501. DOI: 10.1016/j.ygyno.2011.11.037. View

5.
Hope-Ross M, Yannuzzi L, Gragoudas E, Guyer D, Slakter J, Sorenson J . Adverse reactions due to indocyanine green. Ophthalmology. 1994; 101(3):529-33. DOI: 10.1016/s0161-6420(94)31303-0. View